Zeke Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.99M | Buy |
5,442
+1,378
| +34% | +$504K | 0.13% | 74 |
|
|
2022
Q3 | $1.31M | Buy |
4,064
+1
| +0% | +$323 | 0.1% | 102 |
|
|
2022
Q2 | $1.32M | Buy |
4,063
+164
| +4% | +$53.2K | 0.09% | 106 |
|
|
2022
Q1 | $1.12M | Buy |
+3,899
| New | +$1.12M | 0.06% | 128 |
|
|
2020
Q2 | – | Sell |
-1,654
| Closed | -$229K | – | 245 |
|
|
2020
Q1 | $229K | Sell |
1,654
-10,968
| -87% | -$1.52M | 0.06% | 176 |
|
|
2019
Q4 | $1.66M | Sell |
12,622
-663
| -5% | -$87.1K | 0.14% | 123 |
|
|
2019
Q3 | $1.49M | Buy |
13,285
+258
| +2% | +$28.9K | 0.13% | 131 |
|
|
2019
Q2 | $1.44M | Sell |
13,027
-3,072
| -19% | -$340K | 0.14% | 134 |
|
|
2019
Q1 | $2.09M | Sell |
16,099
-10,436
| -39% | -$1.35M | 0.19% | 96 |
|
|
2018
Q4 | $3.07M | Sell |
26,535
-14,184
| -35% | -$1.64M | 0.29% | 71 |
|
|
2018
Q3 | $4.37M | Buy |
40,719
+300
| +0.7% | +$32.2K | 0.36% | 50 |
|
|
2018
Q2 | $3.45M | Buy |
40,419
+12,853
| +47% | +$1.1M | 0.32% | 59 |
|
|
2018
Q1 | $2.13M | Buy |
27,566
+1,905
| +7% | +$147K | 0.2% | 90 |
|
|
2017
Q4 | $2.17M | Buy |
25,661
+1,815
| +8% | +$153K | 0.23% | 72 |
|
|
2017
Q3 | $2.04M | Buy |
23,846
+14,632
| +159% | +$1.25M | 0.28% | 63 |
|
|
2017
Q2 | $758K | Buy |
9,214
+1,828
| +25% | +$150K | 0.15% | 90 |
|
|
2017
Q1 | $621K | Buy |
7,386
+2,468
| +50% | +$208K | 0.13% | 87 |
|
|
2016
Q4 | $362K | Buy |
+4,918
| New | +$362K | 0.1% | 109 |
|